Problem: Type 2 diabetes mellitus requires daily and continuous management by the patient. The development of digital technologies and Artificial Intelligence offers new opportunities for disease monitoring, self-management, treatment adherence, and continuity of care; however, their actual contribution to home-based disease management and the role of nurses in their integration require further investigation. Aim: To analyze the available evidence on the use of digital technologies and Artificial Intelligence in the home management of adults with type 2 diabetes mellitus, with particular attention to glycemic control, self-management, treatment adherence, continuity of care, major barriers, and the nursing role. Sample: Fifteen studies conducted in different geographical settings were included, involving adults with type 2 diabetes mellitus and, in some studies, healthcare professionals. Materials and Methods: A literature review was conducted according to eligibility criteria defined using the PICO framework. The search, carried out from January 12 to August 20, 2026, involved the PubMed, CINAHL, Scopus, and Google Scholar databases, using MeSH terms and keywords combined with Boolean operators. Study selection was performed according to the PRISMA model. Quantitative, qualitative, and development and evaluation studies were considered. Results: The evidence showed heterogeneous findings. Some digital and telemonitoring interventions demonstrated improvements in glycemic control, self-management, and treatment adherence, whereas others did not show statistically significant differences compared with usual care. The findings suggest the importance of continuity of use, personalization, and integration of technology into the care pathway. Critical issues also emerged regarding usability, connectivity, costs, digital skills and health literacy, accessibility, and privacy protection. Artificial Intelligence-based solutions showed potential in supporting treatment management and health literacy, although specific evidence remains limited. Discussion: The findings indicate that the benefits of technology do not depend exclusively on the tool itself, but also on the level of patient engagement, intervention personalization, ease of use, and integration with healthcare professionals. In this context, nurses play a central role in therapeutic education, follow-up, needs assessment, and support for the informed use of technologies. Conclusions: Digital technologies and Artificial Intelligence may represent valuable tools to support the home management of type 2 diabetes mellitus. However, their effectiveness appears to depend on their integration into the care pathway and on maintaining a person-centered approach. Nurse involvement is essential to promote safe, accessible, and personalized use of these technologies. Further studies, particularly those with longer follow-up periods, are needed to define the contribution of Artificial Intelligence to the long-term management of the disease. Keywords: Type 2 diabetes mellitus; Artificial Intelligence; digital health; telemedicine; telemonitoring; self-management; home care; nurse.
Problema: Il diabete mellito di tipo 2 richiede una gestione quotidiana e continuativa da parte della persona assistita. Lo sviluppo delle tecnologie digitali e dell’Intelligenza Artificiale offre nuove possibilità per il monitoraggio della patologia, l’autogestione, l’aderenza terapeutica e la continuità assistenziale, ma il loro effettivo contributo alla gestione domiciliare e il ruolo dell’infermiere nella loro integrazione necessitano di essere approfonditi. Scopo: Analizzare le evidenze disponibili sull’utilizzo delle tecnologie digitali e dell’Intelligenza Artificiale nella gestione domiciliare dell’adulto con diabete mellito di tipo 2, con particolare attenzione al controllo glicemico, all’autogestione, all’aderenza terapeutica, alla continuità assistenziale, alle principali barriere e al ruolo infermieristico. Campione: Sono stati inclusi 15 studi, condotti in diversi contesti geografici, comprendenti persone adulte con diabete mellito di tipo 2 e, in alcuni studi, professionisti sanitari. Materiali e metodi: È stata condotta una revisione della letteratura secondo i criteri di eleggibilità definiti mediante il framework PICO. La ricerca, effettuata dal 12 gennaio al 20 agosto 2026, ha coinvolto le banche dati PubMed, CINAHL, Scopus e Google Scholar, utilizzando termini MeSH e parole chiave combinati mediante operatori booleani. La selezione degli studi è stata condotta secondo il modello PRISMA. Sono stati considerati studi quantitativi, qualitativi e di sviluppo e valutazione. Risultati: Le evidenze hanno mostrato risultati eterogenei. Alcuni interventi digitali e di telemonitoraggio hanno evidenziato miglioramenti del controllo glicemico, dell’autogestione e dell’aderenza, mentre altri non hanno mostrato differenze statisticamente significative rispetto all’assistenza abituale. I risultati suggeriscono l’importanza della continuità di utilizzo, della personalizzazione e dell’integrazione della tecnologia nel percorso assistenziale. Sono emerse inoltre criticità relative a usabilità, connettività, costi, competenze digitali e health literacy, accessibilità e tutela della privacy. Le soluzioni basate sull’Intelligenza Artificiale hanno mostrato potenzialità nel supporto alla gestione della terapia e alla health literacy, sebbene le evidenze specifiche risultino ancora limitate. Discussione: I risultati indicano che il beneficio delle tecnologie non dipende esclusivamente dallo strumento utilizzato, ma anche dal livello di coinvolgimento della persona, dalla personalizzazione dell’intervento, dalla facilità d’uso e dall’integrazione con i professionisti sanitari. In questo contesto, l’infermiere assume un ruolo centrale nell’educazione terapeutica, nel follow-up, nella valutazione dei bisogni e nel supporto all’utilizzo consapevole delle tecnologie. Conclusioni: Le tecnologie digitali e l’Intelligenza Artificiale possono rappresentare strumenti di supporto alla gestione domiciliare del diabete mellito di tipo 2. La loro efficacia appare tuttavia condizionata dall’integrazione nel percorso assistenziale e dalla centralità della persona. Il coinvolgimento dell’infermiere risulta fondamentale per favorire un utilizzo sicuro, accessibile e personalizzato. Sono necessari ulteriori studi, in particolare con follow-up più lunghi, per definire il contributo dell’Intelligenza Artificiale nella gestione a lungo termine della patologia. Parole chiave: diabete mellito di tipo 2; Intelligenza Artificiale; sanità digitale; telemedicina; telemonitoraggio; autogestione; assistenza domiciliare; infermiere.
Innovare la cura, potenziare l’autonomia: Il ruolo dell’infermiere nell’era dell’intelligenza artificiale e della sanità digitale nella gestione domiciliare del diabete mellito di tipo 2
GEROMIN, ANGELA
2025/2026
Abstract
Problem: Type 2 diabetes mellitus requires daily and continuous management by the patient. The development of digital technologies and Artificial Intelligence offers new opportunities for disease monitoring, self-management, treatment adherence, and continuity of care; however, their actual contribution to home-based disease management and the role of nurses in their integration require further investigation. Aim: To analyze the available evidence on the use of digital technologies and Artificial Intelligence in the home management of adults with type 2 diabetes mellitus, with particular attention to glycemic control, self-management, treatment adherence, continuity of care, major barriers, and the nursing role. Sample: Fifteen studies conducted in different geographical settings were included, involving adults with type 2 diabetes mellitus and, in some studies, healthcare professionals. Materials and Methods: A literature review was conducted according to eligibility criteria defined using the PICO framework. The search, carried out from January 12 to August 20, 2026, involved the PubMed, CINAHL, Scopus, and Google Scholar databases, using MeSH terms and keywords combined with Boolean operators. Study selection was performed according to the PRISMA model. Quantitative, qualitative, and development and evaluation studies were considered. Results: The evidence showed heterogeneous findings. Some digital and telemonitoring interventions demonstrated improvements in glycemic control, self-management, and treatment adherence, whereas others did not show statistically significant differences compared with usual care. The findings suggest the importance of continuity of use, personalization, and integration of technology into the care pathway. Critical issues also emerged regarding usability, connectivity, costs, digital skills and health literacy, accessibility, and privacy protection. Artificial Intelligence-based solutions showed potential in supporting treatment management and health literacy, although specific evidence remains limited. Discussion: The findings indicate that the benefits of technology do not depend exclusively on the tool itself, but also on the level of patient engagement, intervention personalization, ease of use, and integration with healthcare professionals. In this context, nurses play a central role in therapeutic education, follow-up, needs assessment, and support for the informed use of technologies. Conclusions: Digital technologies and Artificial Intelligence may represent valuable tools to support the home management of type 2 diabetes mellitus. However, their effectiveness appears to depend on their integration into the care pathway and on maintaining a person-centered approach. Nurse involvement is essential to promote safe, accessible, and personalized use of these technologies. Further studies, particularly those with longer follow-up periods, are needed to define the contribution of Artificial Intelligence to the long-term management of the disease. Keywords: Type 2 diabetes mellitus; Artificial Intelligence; digital health; telemedicine; telemonitoring; self-management; home care; nurse.| File | Dimensione | Formato | |
|---|---|---|---|
|
Geromin_Angela_2115499_pdfA.pdf
Accesso riservato
Dimensione
556.58 kB
Formato
Adobe PDF
|
556.58 kB | Adobe PDF |
The text of this website © Università degli studi di Padova. Full Text are published under a non-exclusive license. Metadata are under a CC0 License
https://hdl.handle.net/20.500.12608/120194